Skip to main content
. 2017 May 19;32(2):145–151. doi: 10.3803/EnM.2017.32.2.145

Table 2. Associations between FGF21 and Cardiovascular Diseases.

CV end-point Result Reference
CV mortality Elevated serum FGF21 predicted combined morbidity and mortality in T2DM [27]
Total CV outcomes Elevated plasma FGF21 [21]
CHD Elevated serum FGF21 [22]
Carotid artery IMT Elevated serum FGF21 [23,24]
Arterial stiffness Brachial-ankle pulse wave velocity independently associated with serum FGF21 [26]
LEAD Elevated serum FGF21 [25]

FGF21, fibroblast growth factor 21; CV, cardiovascular; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease; IMT, intima-media thickness; LEAD, lower extremity atherosclerotic disease.